Dr. Anish Bhatnagar's financial holdings show considerable fluctuations over recent years. His stake in Soleno Therapeutics has varied, reaching significant peaks around mid-2020, where his insider trading hovered between $700K and $1.3M monthly. As of late 2021, his trading slowed,...
Dr. Anish Bhatnagar's financial holdings show considerable fluctuations over recent years. His stake in Soleno Therapeutics has varied, reaching significant peaks around mid-2020, where his insider trading hovered between $700K and $1.3M monthly. As of late 2021, his trading slowed, indicating a shift from active trading strategies to possibly a long-term outlook. Over the past few years, trading values have ranged from $30K to as high as $7M, illustrating a dynamic relationship with his company’s stock. This fluctuation echoes his strategic focus on the company’s long-term health rather than short-term gains, which aligns with his leadership style and vision for Soleno.